Table 4. Open in new tab Factors...

	Urban Clinic	Rural Clinic
	OR (95% CI)		OR (95% CI)
Age (10-y increase)	1.3 (1.1–1.6)	.008	1.3 (1.0–1.6)	.052
Ever used alcohol	0.6 (0.4–0.9)	.016	0.6 (0.4–1.1)	.082
Ever used tobacco	1.5 (0.9–2.5)	.091	2.9 (1.5–5.9)	.003
Ever used herbal medicine	1.2 (0.7–1.9)	.474	1.0 (0.6–1.8)	.949
Hepatitis B surface antigen positive	1.1 (0.7–2.0)	.612	0.4 (0.1–1.1)	.072
Hepatitis C antibody positive	1.9 (0.6–6.0)	.263	2.2 (0.6–9.0)	.259
On ART	-	-	0.6 (0.1–4.9)	.594
Detectable HIV viral load (≥1000 copies/mL)	1.4 (0.6–3.3)	.403	1.4 (0.7–2.9)	.404
Elevated liver transaminases^a	2.3 (1.3–3.9)	.002	2.4 (1.1–5.3)	.028

	Urban Clinic	Rural Clinic
	OR (95% CI)		OR (95% CI)
Age (10-y increase)	1.3 (1.1–1.6)	.008	1.3 (1.0–1.6)	.052
Ever used alcohol	0.6 (0.4–0.9)	.016	0.6 (0.4–1.1)	.082
Ever used tobacco	1.5 (0.9–2.5)	.091	2.9 (1.5–5.9)	.003
Ever used herbal medicine	1.2 (0.7–1.9)	.474	1.0 (0.6–1.8)	.949
Hepatitis B surface antigen positive	1.1 (0.7–2.0)	.612	0.4 (0.1–1.1)	.072
Hepatitis C antibody positive	1.9 (0.6–6.0)	.263	2.2 (0.6–9.0)	.259
On ART	-	-	0.6 (0.1–4.9)	.594
Detectable HIV viral load (≥1000 copies/mL)	1.4 (0.6–3.3)	.403	1.4 (0.7–2.9)	.404
Elevated liver transaminases^a	2.3 (1.3–3.9)	.002	2.4 (1.1–5.3)	.028

Table 4.

Factors Associated With Liver Fibrosis Among HIV-Infected Females Patients Attending the AIDC and GPC Care Clinics in Urban and Rural Uganda (2015–2017)

	Urban Clinic		Rural Clinic
Explanatory variable	Adjusted Analysis	P Value	Adjusted Analysis	P Value
	OR (95% CI)		OR (95% CI)
Age (10-y increase)	1.3 (1.1–1.6)	.008	1.3 (1.0–1.6)	.052
Ever used alcohol	0.6 (0.4–0.9)	.016	0.6 (0.4–1.1)	.082
Ever used tobacco	1.5 (0.9–2.5)	.091	2.9 (1.5–5.9)	.003
Ever used herbal medicine	1.2 (0.7–1.9)	.474	1.0 (0.6–1.8)	.949
Hepatitis B surface antigen positive	1.1 (0.7–2.0)	.612	0.4 (0.1–1.1)	.072
Hepatitis C antibody positive	1.9 (0.6–6.0)	.263	2.2 (0.6–9.0)	.259
On ART	-	-	0.6 (0.1–4.9)	.594
Detectable HIV viral load (≥1000 copies/mL)	1.4 (0.6–3.3)	.403	1.4 (0.7–2.9)	.404
Elevated liver transaminases^a	2.3 (1.3–3.9)	.002	2.4 (1.1–5.3)	.028

	Urban Clinic		Rural Clinic
Explanatory variable	Adjusted Analysis	P Value	Adjusted Analysis	P Value
	OR (95% CI)		OR (95% CI)
Age (10-y increase)	1.3 (1.1–1.6)	.008	1.3 (1.0–1.6)	.052
Ever used alcohol	0.6 (0.4–0.9)	.016	0.6 (0.4–1.1)	.082
Ever used tobacco	1.5 (0.9–2.5)	.091	2.9 (1.5–5.9)	.003
Ever used herbal medicine	1.2 (0.7–1.9)	.474	1.0 (0.6–1.8)	.949
Hepatitis B surface antigen positive	1.1 (0.7–2.0)	.612	0.4 (0.1–1.1)	.072
Hepatitis C antibody positive	1.9 (0.6–6.0)	.263	2.2 (0.6–9.0)	.259
On ART	-	-	0.6 (0.1–4.9)	.594
Detectable HIV viral load (≥1000 copies/mL)	1.4 (0.6–3.3)	.403	1.4 (0.7–2.9)	.404
Elevated liver transaminases^a	2.3 (1.3–3.9)	.002	2.4 (1.1–5.3)	.028

Abbreviations: AIDC, Adult Infectious Diseases Clinic; ART, antiretroviral therapy; GPC, General Population Clinic; OR, odds ratio.

^aAIDS Clinical Trials Group classification.

This Feature Is Available To Subscribers Only